XML 43 R23.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Earnings Per Share | 12 Months Ended
--- | ---
Dec. 31, 2023
Earnings Per Share [Abstract] |
Earnings Per Share | 12. EARNINGS PER SHARE The following table sets forth the components of the denominator for the computation of basic and diluted (loss) earnings per share for net (loss) income attributable to Community Health Systems, Inc. stockholders:
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Weighted-average number of shares outstanding — basic |  |  | 130,445,677 |  |  |  | 128,808,387 |  |  |  | 126,754,852 |
Effect of dilutive securities: |  |  |  |  |  |  |  |  |
Restricted stock awards |  |  | — |  |  |  | 842,055 |  |  |  | 2,803,938 |
Employee stock options |  |  | — |  |  |  | 278,057 |  |  |  | 726,130 |
Other equity-based awards |  |  | — |  |  |  | 131,820 |  |  |  | 312,490 |
Weighted-average number of shares outstanding — diluted |  |  | 130,445,677 |  |  |  | 130,060,319 |  |  |  | 130,597,410 |
The Company generated a net loss attributable to Community Health Systems, Inc. stockholders for the year ended December 31, 2023, so the effect of dilutive securities is not considered because their effect would be antidilutive. If the Company had generated net income, the effect of stock awards and options on the diluted shares calculation would have been an increase of 422,487 shares during the year ended December 31, 2023.
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive: |  |  |  |  |  |  |  |  |
Employee stock options and restricted stock awards |  |  | 6,210,811 |  |  |  | 4,406,764 |  |  |  | 774,981 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration